Your browser doesn't support javascript.
loading
Improvement rates, adverse events and predictors of clinical outcome following surgery for degenerative cervical myelopathy.
de Dios, Eddie; Laesser, Mats; Björkman-Burtscher, Isabella M; Lindhagen, Lars; MacDowall, Anna.
Afiliação
  • de Dios E; Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Region Västra Götaland, Sahlgrenska University Hospital, Bruna stråket 11, 41345, Gothenburg, Sweden. eddie.dedios@gmail.com.
  • Laesser M; Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Region Västra Götaland, Sahlgrenska University Hospital, Bruna stråket 11, 41345, Gothenburg, Sweden.
  • Björkman-Burtscher IM; Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Region Västra Götaland, Sahlgrenska University Hospital, Bruna stråket 11, 41345, Gothenburg, Sweden.
  • Lindhagen L; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • MacDowall A; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Eur Spine J ; 31(12): 3433-3442, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36053323
ABSTRACT

PURPOSE:

To investigate improvement rates, adverse events and predictors of clinical outcome after laminectomy alone (LAM) or laminectomy with instrumented fusion (LAM + F) for degenerative cervical myelopathy (DCM).

METHODS:

This is a post hoc analysis of a previously published DCM cohort. Improvement rates for European myelopathy score (EMS) and Neck Disability Index (NDI) at 2- and 5-year follow-ups and adverse events are presented descriptively for available cases. Predictor endpoints were EMS and NDI scores at follow-ups, surgeon- and patient-reported complications, and reoperation-free interval. For predictors, univariate and multivariable models were fitted to imputed data.

RESULTS:

Mean age of patients (LAM n = 412; LAM + F n = 305) was 68 years, and 37.4% were women. LAM + F patients had more severe spondylolisthesis and less severe kyphosis at baseline, more surgeon-reported complications, more patient-reported complications, and more reoperations (p ≤ 0.05). After imputation, the overall EMS improvement rate was 43.8% at 2 years and 36.3% at 5 years. At follow-ups, worse EMS scores were independent predictors of worse EMS outcomes and older age and worse NDI scores were independent predictors of worse NDI outcomes. LAM + F was associated with more surgeon-reported complications (ratio 1.81; 95% CI 1.17-2.80; p = 0.008). More operated levels were associated with more patient-reported complications (ratio 1.12; 95% CI 1.02-1.22; p = 0.012) and a shorter reoperation-free interval (hazard ratio 1.30; 95% CI 1.08-1.58; p = 0.046).

CONCLUSIONS:

These findings suggest that surgical intervention at an earlier myelopathy stage might be beneficial and that less invasive procedures are preferable in this patient population.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças da Medula Espinal / Vértebras Cervicais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças da Medula Espinal / Vértebras Cervicais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article